CisplatinRadiotherapyRadiotherapy DosageRadiotherapy, AdjuvantRadiotherapy, ConformalCombined Modality TherapyRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedRadiotherapy, High-EnergyAntineoplastic Combined Chemotherapy ProtocolsDose FractionationRadiation InjuriesAntineoplastic AgentsRadiotherapy, Computer-AssistedRadiotherapy, Image-GuidedTreatment OutcomeHead and Neck NeoplasmsLung NeoplasmsNeoplasm StagingCarcinoma, Squamous CellNeoplasm Recurrence, LocalRadiation OncologyDisease-Free SurvivalSurvival AnalysisSurvival RateBrachytherapyDose-Response Relationship, RadiationFluorouracilRadiosurgeryNasopharyngeal NeoplasmsPlatinumDrug Administration ScheduleChemotherapy, AdjuvantRadiation-Sensitizing AgentsChemoradiotherapyEtoposideVinblastineBrain NeoplasmsRetrospective StudiesCarcinoma, Non-Small-Cell LungRadiation ToleranceFollow-Up StudiesPrognosisDeoxycytidineDrug Resistance, NeoplasmDoxorubicinOrgans at RiskAdenocarcinomaCarboplatinCranial IrradiationVincristineNeoplasmsCell Line, TumorRectal NeoplasmsParticle AcceleratorsNeoadjuvant TherapyPaclitaxelBleomycinOvarian NeoplasmsIfosfamideBreast NeoplasmsTime FactorsDacarbazineProstatic NeoplasmsLaryngeal NeoplasmsRadiometryEsophageal NeoplasmsCarcinomaRadiation DosagePelvic NeoplasmsRadiation PneumonitisUterine Cervical NeoplasmsVindesineTesticular NeoplasmsLeukopeniaHodgkin DiseaseDNA AdductsMastectomy, SegmentalSalvage TherapyTomography, X-Ray ComputedCarcinoma, Small CellTaxoidsCyclophosphamideOrgan Sparing TreatmentsAntineoplastic Agents, AlkylatingRadiodermatitisNeoplasms, Second PrimaryHeavy Ion RadiotherapyNeoplasms, Radiation-InducedVomitingProcarbazineAmifostineApoptosisKaplan-Meier EstimateInfusions, IntravenousFeasibility StudiesMitomycinXerostomiaRemission InductionDose-Response Relationship, Drug